Billion
Novartis and Relation Therapeutics form AI-driven, multi-program atopic disease collaboration
Novartis; Relation Therapeutics; AI-powered drug discovery; Lab-in-the-Loop; atopic diseases; immuno-dermatology; multi-program collaboration; asthma; allergies; eczema; allergic rhinitis; $55 million upfront; $1.7 billion milestones; functional cell atlases
Gilead Unveils New Manufacturing Site in California as Part of $32B U.S. Investment Plan
Gilead Sciences; Foster City; California; manufacturing facility; biopharmaceuticals; $32 billion investment; economic impact; expansion; R&D; job creation; U.S. manufacturing
Johnson & Johnson Commits $2B to Fujifilm North Carolina Site in Latest US Manufacturing Push
Johnson & Johnson; Fujifilm; manufacturing; North Carolina; $2 billion investment; biopharma; job creation; US manufacturing
Gilead tees up $11B in new US manufacturing, R&D investments
United States, Investments, Manufacture, R&D, Billion, U.S.
Novartis Partners with Dren Bio in $3 Billion Deal for Targeted Myeloid Engagers
Novartis, Dren Bio, Myeloid Engagers, Biotech, Pharmaceutical, Alliance, $3 Billion Deal
Ipsen Licenses Second ADC via $1B Bet on Foreseen Bio Asset
Ipsen, Foreseen Biotechnology, Antibody-Drug Conjugate (ADC), Licensing Agreement, $1 Billion Deal
Sanofi Seeks Private Equity Bids for $20 Billion Consumer Health Division
Sanofi, Consumer Health, Private Equity, Bids, $20 Billion